Skip to contentL
Longevity Health Holdings, Inc.
L
XAGELongevity Health Holdings, Inc. Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$472.98K$472.98Kderived+2,606.0% vs Q4 2024 Net Income-$2.08M-$2.08MderivedN/M vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Longevity Health Holdings, Inc. · CIK 1842939 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$267,816+1,547.7% Operating Incomederived-$2,271,201N/M Operating Cash Flowderived-$306,367N/M Free Cash Flowderived-$306,368— Margins · derivedGross margin56.6%−36.4 pt vs Q4 2024
Operating margin-480.2%+5280.3 pt vs Q4 2024
Net margin-440.4%+4790.3 pt vs Q4 2024
ended Dec 31, 2025 · filed Mar 31, 2026 · 90 d after period end